We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Pfizer Inc (PFE) stock saw a decline, ending the day at $26.52 which represents a decrease of $-0.39 or -1.45% from the prior close of $26.91. The stock opened at $26.96 and touched a low of $26.42 ...

Bullish option flow detected in Pfizer (PFE) with 33,534 calls trading, 1.3x expected, and implied vol increasing over 1 point to 27.48%. 2/7 ...

Dividend stocks have remained a focal point for investors, especially amid market volatility and the growing need for steady ...

Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the ...

Health experts are seeing signs of a much smaller wave of U.S. COVID-19 cases this winter than in previous years, which could ...

Pfizer (NYSE:PFE) reported positive topline results from a Phase 3 study of its drug Braftovi, also known as encorafenib, in the treatment of a certain type of colorectal cancer. The study, called ...

MADRID - Inspired by Donald Trump's MAGA slogan, parties aligned with the Patriots for Europe group will gather in Madrid on ...

US stock futures fell sharply Monday, with the imposition of tariffs on major trading partners by the Trump administration hitting sentiment. Tesla (NASDAQ:TSLA) stock fell 3.2%, with the EV maker ...

Last week was extremely busy on the earnings front, so this week is a little more sedate. That being said, we still have some ...

Less than two months after an accelerated approval from the FDA, a drug combination featuring Pfizer’s Braftovi has turned in ...